日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient specific real-time PCR in precision medicine - Validation of IG/TR based MRD assessment in lymphoid leukemia

精准医疗中的患者特异性实时PCR——基于IG/TR的淋巴细胞白血病微小残留病(MRD)评估的验证

Schilhabel, Anke; Szczepanowski, Monika; van Gastel-Mol, Ellen J; Schillalies, Janina; Ray, Jill; Kim, Doris; Nováková, Michaela; Dombrink, Isabel; van der Velden, Vincent H J; Boettcher, Sebastian; Brüggemann, Monika; Kneba, Michael; van Dongen, Jacques J M; Langerak, Anton W; Ritgen, Matthias

Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicenter, open-label phase-II trial

苯达莫司汀序贯奥法妥木单抗和伊布替尼治疗慢性淋巴细胞白血病(CLL2-BIO):一项多中心、开放标签 II 期试验的主要终点分析

Cramer, Paula; Tresckow, Julia V; Robrecht, Sandra; Bahlo, Jasmin; Fürstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J; Vehling-Kaiser, Ursula; Dürig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael

Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)

一线治疗中接受 FCR 与 BR 方案治疗的健康状况良好的患者的长期随访数据和健康相关生活质量(GCLLSG 的 CLL10 试验)

Kutsch, Nadine; Bahlo, Jasmin; Robrecht, Sandra; Franklin, Jeremy; Zhang, Can; Maurer, Christian; De Silva, Nisha; Lange, Elisabeth; Weide, Rudolf; Kiehl, Michael G; Sökler, Martin; Schlag, Rudolf; Vehling-Kaiser, Ursula; Köchling, Georg; Plöger, Christoph; Gregor, Michael; Plesner, Torben; Herling, Marco; Fischer, Kirsten; Döhner, Hartmut; Kneba, Michael; Wendtner, Clemens-Martin; Klapper, Wolfram; Kreuzer, Karl-Anton; Böttcher, Sebastian; Stilgenbauer, Stephan; Fink, Anna Maria; Hallek, Michael; Eichhorst, Barbara

Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab

接受苯丁酸氮芥联合奥妥珠单抗或利妥昔单抗治疗的合并症慢性淋巴细胞白血病患者中微小残留病灶的预后价值

Langerak, Anton W; Ritgen, Matthias; Goede, Valentin; Robrecht, Sandra; Bahlo, Jasmin; Fischer, Kirsten; Steurer, Michael; Trněný, Marek; Mulligan, Stephen P; Mey, Ulrich J M; Trunzer, Kerstin; Fingerle-Rowson, Günter; Humphrey, Kathryn; Stilgenbauer, Stephan; Böttcher, Sebastian; Brüggemann, Monika; Hallek, Michael; Kneba, Michael; van Dongen, Jacques J M

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV

伊马替尼剂量减少对慢性粒细胞白血病主要分子学缓解的影响:德国慢性粒细胞白血病研究 IV 的结果

Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M; Heim, Dominik; Brümmendorf, Tim H; Fabarius, Alice; Haferlach, Claudia; Schlegelberger, Brigitte; Balleisen, Leopold; Goebeler, Maria-Elisabeth; Hänel, Mathias; Ho, Anthony; Dengler, Jolanta; Falge, Christiane; Möhle, Robert; Kremers, Stephan; Kneba, Michael; Stegelmann, Frank; Köhne, Claus-Henning; Lindemann, Hans-Walter; Waller, Cornelius F; Spiekermann, Karsten; Berdel, Wolfgang E; Müller, Lothar; Edinger, Matthias; Mayer, Jiri; Beelen, Dietrich W; Bentz, Martin; Link, Hartmut; Hertenstein, Bernd; Fuchs, Roland; Wernli, Martin; Schlegel, Frank; Schlag, Rudolf; de Wit, Maike; Trümper, Lorenz; Hebart, Holger; Hahn, Markus; Thomalla, Jörg; Scheid, Christof; Schafhausen, Philippe; Verbeek, Walter; Eckart, Michael J; Gassmann, Winfried; Schenk, Michael; Brossart, Peter; Wündisch, Thomas; Geer, Thomas; Bildat, Stephan; Schäfer, Erhardt; Hasford, Joerg; Hehlmann, Rüdiger; Pfirrmann, Markus

Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy

慢性中心性浆液性脉络膜视网膜病变消退后视力及视网膜形态受损

Gawęcki, Maciej; Jaszczuk-Maciejewska, Agnieszka; Jurska-Jaśko, Anna; Kneba, Małgorzata; Grzybowski, Andrzej

IG-MYC (+) neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

具有前体B细胞表型的IG-MYC(+)肿瘤在分子水平上与伯基特淋巴瘤不同。

Wagener, Rabea; López, Cristina; Kleinheinz, Kortine; Bausinger, Julia; Aukema, Sietse M; Nagel, Inga; Toprak, Umut H; Seufert, Julian; Altmüller, Janine; Thiele, Holger; Schneider, Christof; Kolarova, Julia; Park, Jeongbin; Hübschmann, Daniel; Murga Penas, Eva M; Drexler, Hans G; Attarbaschi, Andishe; Hovland, Randi; Kjeldsen, Eigil; Kneba, Michael; Kontny, Udo; de Leval, Laurence; Nürnberg, Peter; Oschlies, Ilske; Oscier, David; Schlegelberger, Brigitte; Stilgenbauer, Stephan; Wössmann, Wilhelm; Schlesner, Matthias; Burkhardt, Birgit; Klapper, Wolfram; Jaffe, Elaine S; Küppers, Ralf; Siebert, Reiner

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV

确定慢性粒细胞白血病主要分子缓解的治疗目标:随机 CML 研究 IV 的结果

Saussele, Susanne; Hehlmann, Rüdiger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F; Oppliger Leibundgut, Elisabeth; Heim, Dominik; Krause, Stefan W; Hofmann, Wolf-Karsten; Hasford, Joerg; Pfirrmann, Markus; Müller, Martin C; Hochhaus, Andreas; Lauseker, Michael

Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy

造血干细胞参与 BCR-ABL1 阳性 ALL 可能是 blinatumomab 治疗耐药的潜在机制

Nagel, Inga; Bartels, Marius; Duell, Johannes; Oberg, Hans-Heinrich; Ussat, Sandra; Bruckmueller, Henrike; Ottmann, Oliver; Pfeifer, Heike; Trautmann, Heiko; Gökbuget, Nicola; Caliebe, Almuth; Kabelitz, Dieter; Kneba, Michael; Horst, Heinz-August; Hoelzer, Dieter; Topp, Max S; Cascorbi, Ingolf; Siebert, Reiner; Brüggemann, Monika

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

评估伊马替尼作为慢性粒细胞白血病一线治疗的疗效:随机CML研究IV的10年生存结果及非CML决定因素的影响

Hehlmann, R; Lauseker, M; Saußele, S; Pfirrmann, M; Krause, S; Kolb, H J; Neubauer, A; Hossfeld, D K; Nerl, C; Gratwohl, A; Baerlocher, G M; Heim, D; Brümmendorf, T H; Fabarius, A; Haferlach, C; Schlegelberger, B; Müller, M C; Jeromin, S; Proetel, U; Kohlbrenner, K; Voskanyan, A; Rinaldetti, S; Seifarth, W; Spieß, B; Balleisen, L; Goebeler, M C; Hänel, M; Ho, A; Dengler, J; Falge, C; Kanz, L; Kremers, S; Burchert, A; Kneba, M; Stegelmann, F; Köhne, C A; Lindemann, H W; Waller, C F; Pfreundschuh, M; Spiekermann, K; Berdel, W E; Müller, L; Edinger, M; Mayer, J; Beelen, D W; Bentz, M; Link, H; Hertenstein, B; Fuchs, R; Wernli, M; Schlegel, F; Schlag, R; de Wit, M; Trümper, L; Hebart, H; Hahn, M; Thomalla, J; Scheid, C; Schafhausen, P; Verbeek, W; Eckart, M J; Gassmann, W; Pezzutto, A; Schenk, M; Brossart, P; Geer, T; Bildat, S; Schäfer, E; Hochhaus, A; Hasford, J